CSL Behring, a part of Australia’s’ CSL Limited, today announced that the board of directors of the Italian Medicines Agency ...

Frazier Life Sciences (FLS), a US investment firm focused on innovative therapeutics, has announced the closing of its ...

The US Food and Drug Administration (FDA) is requiring safety labeling changes to all opioid pain medications to better ...

US pharma major Eli Lilly has announced top-line results from SURPASS-CVOT, a first-of-its-kind head-to-head Phase III ...

Esteve CDMO (Esteve Química) - part of privately-held Spanish drugmaker Lab Esteve - has acquired Regis Technologies, a ...

Bristol Myers Squibb (NYSE: BMY) has posted better-than-expected second-quarter 2025 results, driven by strong sales of its ...

Endometriosis remains a complex challenge for patients and drug developers, with GlobalData highlighting five major gaps ...

Shares of Spanish plasma-derived medicines specialist Grifols rose 9% yesterday after it announced results for the first half ...

The US Food and Drug Administration has set prescription drug user fee rates for fiscal year 2026, with increases across all ...

Shares of US pharma major AbbVie were up 6.1% at $200.96 in pre-market activity, as it announced second-quarter 2025 ...

Shares in French pharma major Sanofi were 6% lower late Thursday after the presentation of the company’s second quarter ...

Second quarter 2025 revenues at Teva Pharmaceutical Industries (NYSE: TEVA) came in at $4.18 billion, flat in US dollars, or a decrease of 1% in local currency terms, compared to the same period of ...